109 related articles for article (PubMed ID: 22503060)
1. Acute pure motor demyelinating neuropathy with hyperreflexia and anti-GalNAc-GD1a antibodies.
Kim JK; Kim DS; Kusunoki S; Kim SJ; Yoo BG
Clin Neurol Neurosurg; 2012 Dec; 114(10):1345-7. PubMed ID: 22503060
[No Abstract] [Full Text] [Related]
2. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
3. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
4. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.
Lopate G; Choksi R; Pestronk A
Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971
[TBL] [Abstract][Full Text] [Related]
5. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
[TBL] [Abstract][Full Text] [Related]
6. IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release.
Ortiz N; Rosa R; Gallardo E; Illa I; Tomas J; Aubry J; Sabater M; Santafé M
J Neuroimmunol; 2001 Sep; 119(1):114-23. PubMed ID: 11525808
[TBL] [Abstract][Full Text] [Related]
7. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
9. Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves.
Yoshino H; Ariga T; Suzuki A; Yu RK; Miyatake T
Brain Res; 2008 Aug; 1227():216-20. PubMed ID: 18598683
[TBL] [Abstract][Full Text] [Related]
10. [A case of chronic inflammatory demyelinating neuropathy associated with antibodies to gangliosides GM1 and GalNAc-GD1a].
Tsukaguchi M; Yamada A; Deguchi K; Takeuchi H; Yuki N
Rinsho Shinkeigaku; 1997 Mar; 37(3):228-32. PubMed ID: 9217422
[TBL] [Abstract][Full Text] [Related]
11. GD1a-associated pure motor Guillain-Barré syndrome with hyperreflexia and bilateral papillitis.
Neuwirth C; Mojon D; Weber M
J Clin Neuromuscul Dis; 2010 Mar; 11(3):114-9. PubMed ID: 20215983
[TBL] [Abstract][Full Text] [Related]
12. Anti-GM1 antibodies and impaired blood-nerve barrier may interfere with remyelination in multifocal motor neuropathy.
Kaji R; Hirota N; Oka N; Kohara N; Watanabe T; Nishio T; Kimura J
Muscle Nerve; 1994 Jan; 17(1):108-10. PubMed ID: 8264689
[TBL] [Abstract][Full Text] [Related]
13. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
Yuki N; Yamada M; Sato S; Ohama E; Kawase Y; Ikuta F; Miyatake T
Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262
[TBL] [Abstract][Full Text] [Related]
14. An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice.
Sheikh KA; Zhang G; Gong Y; Schnaar RL; Griffin JW
Ann Neurol; 2004 Aug; 56(2):228-39. PubMed ID: 15293275
[TBL] [Abstract][Full Text] [Related]
15. Anti-GD1a ganglioside antibodies in peripheral motor syndromes.
Carpo M; Nobile-Orazio E; Meucci N; Gamba M; Barbieri S; Allaria S; Scarlato G
Ann Neurol; 1996 Apr; 39(4):539-43. PubMed ID: 8619533
[TBL] [Abstract][Full Text] [Related]
16. Association of IgM type anti-GM1 antibodies and muscle strength in chronic acquired demyelinating polyneuropathy.
Bech E; Andersen H; Orntoft TF; Jakobsen J
Ann Neurol; 1998 Jan; 43(1):72-8. PubMed ID: 9450770
[TBL] [Abstract][Full Text] [Related]
17. [Confrontation at Salpêtrière hospital. March 1992. Progressive amyotrophy of the upper limbs in a man with a 24 years course starting at age 29].
Vighetto A; Hoang-Xuan K; Ben Younes-Chennoufi A; Léger JM
Rev Neurol (Paris); 1994; 150(4):314-21. PubMed ID: 7863187
[No Abstract] [Full Text] [Related]
18. Distal acquired demyelinating symmetric neuropathy associated with anti-GM1 antibodies: is this a CIDP variant?
Remiche G; Kentos A; Mavroudakis N
Acta Neurol Belg; 2010 Mar; 110(1):103-6. PubMed ID: 20514936
[TBL] [Abstract][Full Text] [Related]
19. Anti-ganglioside antibodies in peripheral neuropathy.
McCombe PA; Wilson R; Prentice RL
Clin Exp Neurol; 1992; 29():182-8. PubMed ID: 1343861
[TBL] [Abstract][Full Text] [Related]
20. Demyelinating symmetric motor polyneuropathy with high anti-GM1 antibody titer: do we need to split?
Galassi G
Muscle Nerve; 2011 Jul; 44(1):147-8; author reply 148. PubMed ID: 21660986
[No Abstract] [Full Text] [Related]
[Next] [New Search]
